Hofseth BioCare ASA (HOFBF)
| Previous Close | 0.2200 |
| Open | 0.1700 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.1700 - 0.1700 |
| 52 Week Range | 0.1700 - 1.0000 |
| Volume | |
| Avg. Volume | 1,071 |
| Market Cap | 75.265M |
| Beta (5Y Monthly) | 0.44 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Hofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORT
The first quarter of 2024 continued on the positive trend for HBC. Sales revenues came in at NOK 52m vs NOK 44m last year, a growth of 17 % YoY. The underlying growth we are seeing is coming from both the ingredients business and finished products channels. The ingredients business continues to have solid demand growth especially for our core petfood products, and we have seen increased demand for our premium pure SPH product within this segment. We are also excited to have launched two new prod
- GlobeNewswire
Hofseth Biocare ASA: Annual General Meeting completed
Hofseth BioCare ASA held its Annual General Meeting on 10 May 2024. 270,174,810 shares, amounting to 68.38 per cent of the share capital, were represent in the meeting or by proxy. All proposals were resolved as presented in the notice issued on 19 April 2024 and the recommendations from the Election committee. The minutes from the Annual General Meeting are attached. For further information, please contact: Jon Olav Ødegård, CEO at HBC Phone: +47 936 32 966 E-mail: joo@hofsethbiocare.no About H
- GlobeNewswire
Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024
The Annual General Meeting of Hofseth BioCare ASA for 2024 will be held at the company's premises at Keiser Wilhelms gate 24, 6003 Ålesund, on 10 May 2024 at 13:00 CET. The notice of the Annual General Meeting is attached. For further information, please contact: Jon Olav Ødegård, CEO of Hofseth BioCare ASA Phone: +47 93632966 E-mail: investor@hofsethbiocare.no About Hofseth BioCare ASA: HBC is a Norwegian consumer and pet health ingredient supplier and an incubator for new pharmaceutical drug l
